Herbal therapy for management of obesity: Observations from a clinical endocrinology practice

Endocrine Practice

Volumn 7, Issue 6, 2001, Pages 443-447

  Sindler, B H ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLEAN; HERBACEOUS AGENT; PHENTERMINE; SATIETE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; DIET; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG MANUFACTURE; DRUG PURITY; DRUG SAFETY; ENDOCRINOLOGY; EXERCISE; FEMALE; HERBAL MEDICINE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PUBLIC HEALTH; QUALITY CONTROL; RETROSPECTIVE STUDY; SIDE EFFECT; UNITED STATES; WEIGHT REDUCTION;

EID: 0035199039     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/ep.7.6.443     Document Type: Article

References (36)

1. The spread of the obesity epidemic in the United States, 1991-1998
2. Guidelines for healthy weight
3. Body-mass index and mortality in a prospective cohort of U.S. adults
4. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women
5. Visceral adiposity and incident coronary heart disease in Japanese-American men: The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study
6. Increasing incidence of type 2 diabetes in the third millennium: Is abdominal fat the central issue?
7. Drug therapy for obesity: Clinical considerations
8. Nonpharmacologic and pharmacologic management of weight gain
9. Sibutramine produces dose-related weight loss
10. Long term weight loss with sibutramine
11. Ginkgo biloba for dementia
12. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)
13. Cancer and herbs
14. Annual deaths attributable to obesity in the United States
15. Overweight and cancer
16. Development of the multiple metabolic syndrome: An epidemiologic perspective
17. A metabolic syndrome in whites and African-Americans: The Atherosclerosis Risk in Communities baseline study
18. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years [erratum in Am J Epidemiol. 1995;142:369]
19. Beneficial health effects of modest weight loss
20. AACE/ACE position statement on the prevention, diagnosis, and treatment of obesity (1998 revision)
21. Norepinephrine, epinephrine, and the sympathomimetic amines
22. Tissue distribution of beta 3-adrenergic receptor mRNA in man
23. A pathogenic role of visceral fat beta 3-adrenoreceptors in obesity
24. A comparison of observational studies and randomized, clinical trials
25. Randomized controlled trials, observational studies, and the hierarchy of research designs
26. Hypericum extract versus imipramine or placebo in patients with moderate depression: Randomized multicentre study of treatment for eight weeks [erratum in BMJ. 2000;320:361]
27. Efficacy of kava extract for treating anxiety: Systematic review and meta-analysis
28. Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes
29. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: A randomized controlled trial [erratum in JAMA. 1999;281:1174]
30. Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults
31. Herbal Ephedra/caffeine for weight loss: A six-month safety and efficacy trial
32. Adverse cardiovascular and central nervous system events associated with dietary supplements containing Ephedra alkaloids
33. The FDA, regulation, and the risk of stroke
34. Dietary supplements containing Ephedra alkaloids